patient_id	diagnosis	specific_diagnosis	lab_id	specimen_type	run_type	inhibitor	replicant	well_concentration	normalized_viability	time_of_read	id
1027	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	13-00123	Peripheral Blood	Standard	Gefitinib	2	10	66.5902099609375	24	1027-Gefitinib-2-13-00123
1027	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	13-00123	Peripheral Blood	Standard	Gefitinib	2	3.33333	76.6626739501953	24	1027-Gefitinib-2-13-00123
1027	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	13-00123	Peripheral Blood	Standard	Gefitinib	2	1.11111	84.2170257568359	24	1027-Gefitinib-2-13-00123
1027	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	13-00123	Peripheral Blood	Standard	Gefitinib	2	0.37037	84.2170257568359	24	1027-Gefitinib-2-13-00123
1027	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	13-00123	Peripheral Blood	Standard	Gefitinib	2	0.123457	91.211799621582	24	1027-Gefitinib-2-13-00123
1027	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	13-00123	Peripheral Blood	Standard	Gefitinib	2	0.041152	92.0511703491211	24	1027-Gefitinib-2-13-00123
1027	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	13-00123	Peripheral Blood	Standard	Gefitinib	2	0.013717	219.076187133789	24	1027-Gefitinib-2-13-00123
